Late Phase Drug Development World Europe 2011 - The big idea

Late Phase Drug Development World Europe 2011 is one of the largest gatherings of pharmaceutical and biotech professionals in Europe

What is your end goal in your late phase drug development strategy? Is it to meet post-marketing commitments; be more efficient in evaluating real world safety and effectiveness data; maximise the commercial benefits of a drug; meet regulatory requirements or be efficient in patient communication? Late Phase Drug Development World Europe 2011 will equip you with the tools to achieve these individual targets and unite all elements to strengthen your overall late phase strategy.
To guarantee a successful late phase drug development strategy you need to ensure you are ahead of the game and are meeting the challenges faced in phase IIIb/IV research, post approval studies, observational research and health outcomes. Late Phase Drug Development World Europe 2011 can do this for you with its excellent speakers, focused content and plentiful networking opportunities.

Late Phase Drug Development World Europe, an impressive two year track record:

Over 100 attendees
From across the globe
Senior decision makers

Don’t just take our word for it:

“The content covered by the various speakers was very informative and met my expectations. The meeting was well organized with sufficient breaks, with time for interaction. All the speakers were well prepared and represented all the areas that I would like to hear from.”
Associate Medical Director, Takeda Global Research

“The relevant people that I wanted to meet were here and great insight to late phase drug development.”
Business Development Manager, CISIV Ltd

Sponsor Late Phase Drug Development World Europe 2011 ›

Premium sponsor